Combination antiretroviral therapy accelerates immune recovery in patients with HIV-related lymphoma treated with EPOCH: a comparison within one prospective trial AMC034.

about

Combination antiretroviral therapy accelerates immune recovery in patients with HIV-related lymphoma treated with EPOCH: a comparison within one prospective trial AMC034.

Item

http://www.wikidata.org/entity/Q47436144

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Combination antiretroviral the ...... one prospective trial AMC034.

@en

Combination antiretroviral the ...... one prospective trial AMC034.

@nl

type

Item

label

Combination antiretroviral the ...... one prospective trial AMC034.

@en

Combination antiretroviral the ...... one prospective trial AMC034.

@nl

prefLabel

Combination antiretroviral the ...... one prospective trial AMC034.

@en

Combination antiretroviral the ...... one prospective trial AMC034.

@nl

P1476

Combination antiretroviral the ...... one prospective trial AMC034.

@en

P2093

Ariela Noy

http://www.w3.org/2001/XMLSchema#string

Carlyn Rose C Tan

http://www.w3.org/2001/XMLSchema#string

Jeannette Lee

http://www.w3.org/2001/XMLSchema#string

Joseph A Sparano

http://www.w3.org/2001/XMLSchema#string

Michelle A Rudek

http://www.w3.org/2001/XMLSchema#string

Stefan K Barta

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacogenomics knowledge for personalized medicine

How I treat HIV-associated lymphoma

Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. A prospective multi-institutional trial

CD4+ count-guided interruption of antiretroviral treatment

Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.

Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.

Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study.

Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma.

Early versus delayed fixed dose combination abacavir/lamivudine/zidovudine in patients with HIV and tuberculosis in Tanzania.

Early versus delayed initiation of antiretroviral therapy for Indian HIV-Infected individuals with tuberculosis on antituberculosis treatment

P304

1-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10428194.2017.1403597

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29160731

http://www.w3.org/2001/XMLSchema#string

P932

5962410

http://www.w3.org/2001/XMLSchema#string